City Holding CO Novo Nordisk A S Transaction History

City Holding CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$90.94 - $199.54 $59,383 - $130,299	653 Added 100.0%	1,306 $118,000
Q2 2023 Jul 13, 2023	BUY	$155.98 - $172.65 $101,854 - $112,740	653 New	653 $105,000
Q3 2018 Oct 15, 2018	SELL	$46.76 - $51.24 $4,348 - $4,765	-93 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $3,826 - $4,577	93	93 $4,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

Stay updated on City Holding CO with notifications on news.